Targeting cell cycle has become the gold standard for metastatic breast cancer (MBC). being cyclin-dependent kinase inhibitors (CDKIs) cornerstones of its treatment. alongside radiotherapy (RT). To date. https://mabelandfoxs.shop/product-category/suitcase/